Surface Oncology to Participate in the 2023 Guggenheim
CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology
Globe Newswire2-02-2023, 20:05
Webull Securities (Singapore) Pte. Ltd. Celebrates First Anniversary and Continues to Expand Across Asia-Pacific 19-05-2023, 08:00